Thompson Street Capital buys Maravia’s Vector Laboratories unit

The St. Louis private equity firm is expected to leverage its knowledge of the research reagents space to position the company for both organic and strategic growth.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this